Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Retained Earnings (2017 - 2026)

AdaptHealth has reported Retained Earnings over the past 9 years, most recently at $78000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.01% year-over-year to $78000.0; the TTM value through Dec 2025 reached $78000.0, up 100.01%, while the annual FY2025 figure was $78000.0, 100.01% up from the prior year.
  • Retained Earnings for Q4 2025 was $78000.0 at AdaptHealth, down from $569000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $42.0 million in Q1 2023 and troughed at -$654.7 million in Q1 2024.
  • A 5-year average of -$101.7 million and a median of $1.6 million in 2024 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: skyrocketed 1155.56% in 2022 and later plummeted 13005.83% in 2024.
  • Year by year, Retained Earnings stood at -$43.0 million in 2021, then soared by 120.21% to $8.7 million in 2022, then crashed by 49.89% to $4.4 million in 2023, then plummeted by 13005.83% to -$562.2 million in 2024, then skyrocketed by 100.01% to $78000.0 in 2025.
  • Business Quant data shows Retained Earnings for AHCO at $78000.0 in Q4 2025, $569000.0 in Q3 2025, and -$554.7 million in Q2 2025.